KMI vs PRAX · P/E 24, rev $9.30B vs $7.38B cap
Kinder Morgan Inc (KMI) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the KMI and PRAX stock pages for the full models.
Not investment advice.